| Code | Description | Claims | Beneficiaries | Total Paid |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
876 |
851 |
$79K |
| 90460 |
Immunization administration through 18 years of age via any route, first or only component |
1,683 |
1,433 |
$55K |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
987 |
972 |
$53K |
| S0302 |
Completed early periodic screening diagnosis and treatment (epsdt) service (list in addition to code for appropriate evaluation and management service) |
1,914 |
1,910 |
$17K |
| 99393 |
Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) |
192 |
192 |
$16K |
| 99392 |
Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) |
120 |
120 |
$10K |
| 90461 |
|
258 |
258 |
$10K |
| 96110 |
Developmental screening, with scoring and documentation, per standardized instrument |
766 |
762 |
$8K |
| 96127 |
|
764 |
763 |
$8K |
| 99391 |
Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) |
98 |
98 |
$8K |
| 99394 |
Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) |
81 |
81 |
$7K |
| 85025 |
Blood count; complete (CBC), automated, and automated differential WBC count |
981 |
980 |
$7K |
| 87502 |
Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets |
82 |
82 |
$6K |
| 36416 |
|
453 |
450 |
$5K |
| 90471 |
Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine |
187 |
187 |
$4K |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
53 |
53 |
$3K |
| 0071A |
|
56 |
56 |
$3K |
| 87651 |
Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe |
79 |
79 |
$2K |
| 0072A |
|
37 |
37 |
$2K |
| G2023 |
Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source |
35 |
35 |
$1K |
| 99173 |
|
12 |
12 |
$266.64 |
| 99050 |
|
12 |
12 |
$198.72 |
| 83655 |
|
13 |
13 |
$143.65 |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
12 |
12 |
$141.72 |
| 87081 |
|
12 |
12 |
$82.08 |
| 94760 |
|
31 |
31 |
$70.73 |